Breast cancer cells deficient in UBE2O show reduced glycolytic metabolites (such as glucose-6-phosphate and fructose-6-phosphate), smaller cell size, and impaired purine/amino acid biosynthesis—key processes that support rapid proliferation [16]. This evidence concerns the gene UBE2O and breast carcinoma.